Hospira, Inc. (HSP) Tops Q2 EPS by 2c

Hospira, Inc. (NYSE: HSP) reported Q2 EPS of $0.51, $0.02 better than the analyst estimate of $0.49. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $987.02 million.

Hospira, Inc. reaffirmed FY2012 guidance.

For earnings history and earnings-related data on Hospira, Inc. (HSP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• HSBC starts SpaceX at Hold, sees execution risks tempering long-term AI ambitions
• AppFolio (APPF) Tops Q2 EPS by 2c ; Offers Guidance